Trials / Recruiting
RecruitingNCT05350891
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
A Prospective, Single-arm, Multicenter Clinical Study of Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent Nasopharyngeal Carcinoma
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 77 (estimated)
- Sponsor
- Eye & ENT Hospital of Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective, Single-arm, Multicenter Clinical Study of Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent Nasopharyngeal Carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | endoscopic surgery | endoscopic surgery combined with adjuvant immunotherapy with/without chemotherapy |
Timeline
- Start date
- 2022-05-08
- Primary completion
- 2026-05-08
- Completion
- 2026-05-08
- First posted
- 2022-04-28
- Last updated
- 2022-05-10
Locations
8 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05350891. Inclusion in this directory is not an endorsement.